Filtros : "Melo, Katherine Jasmine Curo" "Inglês" Removido: "FERRAZ, HUMBERTO GOMES" Limpar

Filtros



Refine with date range


  • Source: Colloids and Surfaces A: Physicochemical and Engineering Aspects. Unidade: FCF

    Subjects: TUBERCULOSE, QUITOSANA, NANOTECNOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HENOSTROZA, Mirla Anali Bazán et al. Cationic rifampicin nanoemulsion for the treatment of ocular tuberculosis. Colloids and Surfaces A: Physicochemical and Engineering Aspects, v. 597, p. 1-11 art. 124755, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.colsurfa.2020.124755. Acesso em: 01 nov. 2024.
    • APA

      Henostroza, M. A. B., Melo, K. J. C., Yukuyama, M. N., Löbenberg, R., & Bou-Chacra, N. A. (2020). Cationic rifampicin nanoemulsion for the treatment of ocular tuberculosis. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 597, 1-11 art. 124755. doi:10.1016/j.colsurfa.2020.124755
    • NLM

      Henostroza MAB, Melo KJC, Yukuyama MN, Löbenberg R, Bou-Chacra NA. Cationic rifampicin nanoemulsion for the treatment of ocular tuberculosis [Internet]. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2020 ; 597 1-11 art. 124755.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.colsurfa.2020.124755
    • Vancouver

      Henostroza MAB, Melo KJC, Yukuyama MN, Löbenberg R, Bou-Chacra NA. Cationic rifampicin nanoemulsion for the treatment of ocular tuberculosis [Internet]. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2020 ; 597 1-11 art. 124755.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.colsurfa.2020.124755
  • Source: Materials Science and Engineering: C. Unidade: FCF

    Subjects: TUBERCULOSE, ANTIBIÓTICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MELO, Katherine Jasmine Curo et al. Rifampicin nanocrystals: towards an innovative approach to treat tuberculosis. Materials Science and Engineering: C, v. 112, p. 1-13 art. 110895, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.msec.2020.110895. Acesso em: 01 nov. 2024.
    • APA

      Melo, K. J. C., Henostroza, M. A. B., Löbenberg, R., & Bou-Chacra, N. A. (2020). Rifampicin nanocrystals: towards an innovative approach to treat tuberculosis. Materials Science and Engineering: C, 112, 1-13 art. 110895. doi:10.1016/j.msec.2020.110895
    • NLM

      Melo KJC, Henostroza MAB, Löbenberg R, Bou-Chacra NA. Rifampicin nanocrystals: towards an innovative approach to treat tuberculosis [Internet]. Materials Science and Engineering: C. 2020 ; 112 1-13 art. 110895.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.msec.2020.110895
    • Vancouver

      Melo KJC, Henostroza MAB, Löbenberg R, Bou-Chacra NA. Rifampicin nanocrystals: towards an innovative approach to treat tuberculosis [Internet]. Materials Science and Engineering: C. 2020 ; 112 1-13 art. 110895.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.msec.2020.110895
  • Source: AAPS Journal. Unidade: FCF

    Subjects: SOLUBILIDADE, BIOFARMÁCIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BOU-CHACRA, Nadia Araci et al. Evolution of choice of solubility and dissolution media after two decades of biopharmaceutical classification system. AAPS Journal, v. 19, n. 4, p. 989-1001, 2017Tradução . . Disponível em: https://doi.org/10.1208/s12248-017-0085-5. Acesso em: 01 nov. 2024.
    • APA

      Bou-Chacra, N. A., Melo, K. J. C., Morales, I. A. C., Stippler, E. S., Kesisoglou, F., Yazdanian, M., & Löbenberg, R. (2017). Evolution of choice of solubility and dissolution media after two decades of biopharmaceutical classification system. AAPS Journal, 19( 4), 989-1001. doi:10.1208/s12248-017-0085-5
    • NLM

      Bou-Chacra NA, Melo KJC, Morales IAC, Stippler ES, Kesisoglou F, Yazdanian M, Löbenberg R. Evolution of choice of solubility and dissolution media after two decades of biopharmaceutical classification system [Internet]. AAPS Journal. 2017 ; 19( 4): 989-1001.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1208/s12248-017-0085-5
    • Vancouver

      Bou-Chacra NA, Melo KJC, Morales IAC, Stippler ES, Kesisoglou F, Yazdanian M, Löbenberg R. Evolution of choice of solubility and dissolution media after two decades of biopharmaceutical classification system [Internet]. AAPS Journal. 2017 ; 19( 4): 989-1001.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1208/s12248-017-0085-5
  • Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF

    Subjects: TUBERCULOSE, HOMOGENEIZAÇÃO

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MELO, Katherine Jasmine Curo e BOU-CHACRA, Nadia Araci. Impact of different stabilizers on the development of rifampin nanosuspension using high-energy milling (HEM) and high-pressure homogenization (HPH). Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 01 nov. 2024. , 2015
    • APA

      Melo, K. J. C., & Bou-Chacra, N. A. (2015). Impact of different stabilizers on the development of rifampin nanosuspension using high-energy milling (HEM) and high-pressure homogenization (HPH). Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
    • NLM

      Melo KJC, Bou-Chacra NA. Impact of different stabilizers on the development of rifampin nanosuspension using high-energy milling (HEM) and high-pressure homogenization (HPH). Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 5 res. FCF005.[citado 2024 nov. 01 ]
    • Vancouver

      Melo KJC, Bou-Chacra NA. Impact of different stabilizers on the development of rifampin nanosuspension using high-energy milling (HEM) and high-pressure homogenization (HPH). Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 5 res. FCF005.[citado 2024 nov. 01 ]

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024